Reduction of Serum Interleukin-1-Like Activity After Treatment With Dexamethasone
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The ability of steroids to modulate the appearance of interleukin-1(IL-1) in vivo was evaluated in a model of endotoxin shock. High levels of IL-1 were found in serum from A/J mice which were sensitized with P. acnes and challenged with bacterial lipopolysaccharide (LPS). The factor appeared in the serum 2–4 hours after LPS challenge and was dependent on the period of P. acnes sensitization and the dose of LPS. Treating the mice with dexamethasone prior to LPS challenge resulted in significantly lower thymocyte proliferative activity in the serum. Three experiments demonstrated that this reduced activity reflects a decrease in IL-1. 1) The reduced activity was not due to the presence of proliferation inhibitors since mixing the serum from dexamethasone-treated mice with purified IL-1 or adding the equivalent amount of steroid directly to thymocyte cultures did not reduce the degree of proliferation. 2) When the serum was fractionated by gel filtration, the proliferative activity for both control and steroid treated sera eluted at 10–16 kilodaltons; however, the activity was nearly 50% less in the sample from steroid-treated mice. 3) In addition to thymocyte proliferative activity, IL-1 induces an increase in the serum titer of the acute phase protein known as serum amyloid A. Both serum- and gel- purified samples were able to induce the SAA, but again the samples from steroid-treated mice were much less active. We conclude that the factor produced in vivo has the properties of IL-1 and that the serum titre of the factor is reduced by dexamethasone treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532 · cited 1×
“Serum from such mice was capable of causing tumor necrosis (TNS activity) [2,22], inducing antibody production by nude splenocytes [BAF (IL-i) activity] [8], and enhancing mitogen-induced T cell proliferation [LAF (IL-i) activity] [11,22].”
Background
Cited by
The Immune-Hypothalamic-Pituitary-Adrenal Axis*
BATEMAN, A., SINGH, A., KRAL, T., & SOLOMON, S. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-1-92 · Cited by 676
Lee, S. W., Tsou, A. P., Chan, H., Thomas, J., Petrie, K., Eugui, E. M., & Allison, A. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1204 · Cited by 506
Zuckerman, S. H., Shellhaas, J., & Butter, L. D. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190213 · Cited by 329
An overview of glucocorticoid anti-inflammatory actions
Schleimer, R. P. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf01844196 · Cited by 199
“GCs have been demonstrated to inhibit the release of IL-1 and TNF in vivo in animals, and in vitro, using both animal and human tissues [29-31].”
BackgroundCytokines and the immune response
Van der Meide, P. H., & Schellekens, H. (1996) · Biotherapy · doi:10.1007/bf01877210 · Cited by 166
Metadata
- Authors
- Staruch, M. J., & Wood, D. D.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 1985-02-01
- Volume
- 37
- Issue
- 2
- Pages
- 193-207
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W1931089900
- Cited by
- 91
- References
- 1
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.